EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer Therapeutics

Jiayu Wang, Jifa Zhang, Jiaxing Wang, Xinyue Hu, Liang Ouyang iD, Yuxi Wang iD

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.2c01655 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Jiayu Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network,…. Hauptthemen laut MEDLINE: Toll-Like Receptors, Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 189 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Department of Science and Technology of Sichuan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toll-like receptors (TLRs) are key components of the innate immune system and serve as a crucial link between innate and acquired immunity. In addition to immune function, TLRs are involved in other important pathological processes, including tumorigenesis. TLRs have dual regulatory effects on tumor immunity by activating nuclear factor κ-B signaling pathways, which induce tumor immune evasion or enhance the antitumor immune response. Therefore, TLRs have become a popular target for cancer prevention and treatment, and TLR agonists and antagonists offer considerable potential for drug development. The TLR7 agonist imiquimod (1) has been approved by the U.S. Food and Drug Administration as a treatment for malignant skin cancer. Herein, the structure, signaling pathways, and function of the TLR family are summarized, and the structure-activity relationships associated with TLR selective and multitarget modulators and their potential application in tumor therapy are systematically discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like ReceptorsNeoplasmsHumansSignal TransductionImiquimodAdjuvants, ImmunologicImmunity, Innate

Substanzen

Toll-Like ReceptorsImiquimodAdjuvants, Immunologic

Autor:innen und Institutionen

  • Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Joint Research Institution of Altitude Health, National Clinical Rese…
  • College of Life Sciences, Sichuan University, Chengdu 610064, Sichuan, China.
  • State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
  • Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.

ORCID-Profile: Liang Ouyang, Yuxi Wang

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • Department of Science and Technology of Sichuan Province
  • National Natural Science Foundation of China

Zitieren

APA

Wang, J., Zhang, J., Wang, J., Hu, X., Ouyang, L., & Wang, Y. (2023). Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer Therapeutics. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c01655

Vancouver

Wang J, Zhang J, Wang J, Hu X, Ouyang L, Wang Y. Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer Therapeutics. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c01655

BibTeX
@article{Wang2023,
  author = {Wang, Jiayu and Zhang, Jifa and Wang, Jiaxing and Hu, Xinyue and Ouyang, Liang and Wang, Yuxi},
  title = {Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer Therapeutics},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.2c01655}
}
Kostenlos starten →